Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stocks - S&P 500 Tops 3,000 on Reopening Optimism

Published 2020-05-26, 12:37 p/m
Updated 2020-05-26, 12:49 p/m
© Reuters.

By Yasin Ebrahim 

Investing.com - Wall Street soared on Tuesday as ongoing efforts to reopen states nationwide and hopes for a Covid-19 vaccine boosted investor sentiment.

The Dow Jones Industrial Average rose 2.51%, or 612 points, the S&P 500 gained 1.78% to rise above 3,000 for the first time since March 5, while the Nasdaq Composite added 1%.

The race for a potential vaccine continues to heat up, with Novavax (NASDAQ:NVAX) rallying more than 13% after the drugmaker said it had begun human trials for its potential coronavirus vaccine.

Merck (NYSE:MRK) climbed about 2% after it said it had teamed up with scientific research company IAVI to develop a potential vaccine.

Easing fears that reopening the economy could trigger a wave of infections also supported sentiment following data showing states that reopened before the start of May have seen a 29% reported drop in cases over the past three weeks, according to CNBC.

On the economic front, investors mulled mixed data as consumer confidence undershot expectations, but housing activity continued to rebound.

The Conference Board’s consumer confidence gauge rose to a reading of 86.6 in May from 85.7 the prior month, missing economists’ forecasts for a reading of 88. New home sales jumped to 623,000, topping economists' forecasts of 490,000.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.